Arkolith/Insider Trading/LRMR/Form 4

Deerfield Mgmt L.P.

Director, 10% OwnerLarimar Therapeutics, Inc. (LRMR) · full profile →Form 4 · filed Feb 16, 2024
Net Buying
Open-Market Buys
$37.5M
Open-Market Sells
$0
Net Open-Market Flow
$37.5M
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 16, 2024Buy(P)1.4M$8.74$12.5M6.2M
Feb 16, 2024Buy(P)1.4M$8.74$12.5M6.2M
Feb 16, 2024Buy(P)1.4M$8.74$12.5M4.2M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193805-24-000245) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML